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UNIT A15.2Hepatic MRI for GE Scanners
MRI techniques continue to evolve rapidly, but the basic components of a liver exami-
nation, and the clinical role of each component, have changed little. The three most
important considerations for choosing techniques for imaging the liver continue to be
contrast, motion artifact, and coverage. In particular, the approach to motion has evolved
from averaging to motion compensation to suspended respiration and/or subsecond
imaging.
This unit is written as an alternate to UNIT A15.1, which bases recommendations on
experience using Siemens MRI equipment. The authors’ experience has been acquired
primarily using General Electric equipment. However, these basic approaches to hepatic
MR imaging are quite similar, with most details relating to minor vendor-specific
differences.
BASIC
PROTOCOL
LIVER IMAGING
Whenever possible, it is best to image the entire liver during a single breath-hold
sequence. The advantages of single breath-hold coverage include simplicity and avoid-
ance of misregistration. Single breath-hold imaging being essential for dynamic mul-
tiphasic imaging must be emphasized; the crucial arterial phase can only be acquired
during a brief interval of ∼20 sec. Whenever possible, patients should be triaged to MRI
machines that have this capability. The abdomen ranks along with the heart and vascular
system as body parts demanding the most up-to-date MRI hardware and software for
successful use.
Several years ago, successful use of MRI for imaging the liver usually involved close
involvement of the senior MR radiologist with each scanning procedure. During the ≥60
min that these exams often required, the radiologist would spend much of his/her time
behind the scanner discussing the details of next pulse sequence with the technologist
during the 5 to 10 min that would elapse during each sequence acquisition. Cases would
be read between exams.
Times have changed. Markedly increased caseloads and decreased reimbursements no
longer permit this luxury. Hepatic MRI can only become a viable procedure for routine
use if the execution of protocols can be trusted to a trained technologist, freeing the
radiologist to read cases and interact with referring clinicians. Fortunately, hardware and
software improvements now permit this, and the comprehensive hepatic MRI protocol
described here should not require >30 min of MRI scanner time. Continued improvements
in the scanner interface will allow these exams to be completed in ∼10 min; actual image
acquisition is <5 min, with all images acquired during breath holding. These sequences
require the patient to be able to suspend respiration for ∼25 sec. It is imperative that there
is clear communication between the technologist and the patient throughout the exam. If
patients are unable to cooperate with this, there are alternative pulse sequences that can
be used to yield images of acceptable quality.
Table A15.2.1 lists the hardware necessary to perform the procedure, along with appro-
priate parameters.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
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Materials
Normal saline (0.9% NaCl), sterile, 100 ml minimum
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), 20 ml for
most patients
22-G angiocatheter
110-in. extension tubing
Set up patient and equipment
1. Interview (screen) the patient to assess for contraindications such as cardiac pace-
maker, implanted mechanical devices, and/or ferromagnetic materials. Also, deter-
mine if the patient will need sedation medication necessitating the need for
appropriate monitoring equipment.
Generally, standard screening forms (APPENDIX 1) are used for all patients screened in a
magnetic resonance system.
The presence of ferromagnetic materials may be a health hazard to the patient while in the
magnetic field and/or adversely affect image quality. To determine the safety of scanning
such ferromagnetic materials see Shellock and Kanal (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain X-rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. Request the patient to change into a gown to eliminate any metal that might be found
in clothing. Ask the patient to remove all personal effects such as jewelry, hearing
aids, glasses, etc., prior to entering the MRI scan room.
All personal belongings should be secured during the examination.
3. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask if they have any questions; answer
appropriately. If this is a research protocol, have the patient sign any necessary
consent forms.
4. Obtain intravenous (i.v.) access utilizing a 22-G angiocatheter and attach to saline
filled extension tubing (110-in.), with saline set to slow infusion by gravity drip.
Secure position of angiocatheter with sterile, clear occlusive dressing.
Table A15.2.1 Equipment Specifications Needed to Perform Imaging
Sequences
Coil type Torso phased array coil
Manufacturer and system type GE Signa
Field strength 1.5 T
Gradient strength 25 mT/m (or whatever the system permits)
Knee cushion Yes
Pulse oximeter If patient requires sedation
Power injector Yes, if available
Normal saline Yes
35-in. extension tubing Yes
Use of contrast agents Yes
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Obtaining i.v. access prior to entering the scan room will promote patient throughput and
eliminate “dead” time of starting the i.v. while the patient is on the exam table. Follow
power injector manufacturer guidelines with regard to appropriate needle gauge/angio-
catheter to be used; this will depend on the chosen injection/flow rates.
If one does not have access to a power injector, one will still be able to perform dynamic
liver imaging. In this case, draw-up the contrast agent in one 20-ml syringe and saline in
two others to flush the timing and examination boluses. Alternatively, larger syringes can
be used, drawing 20-ml of contrast agent into one and 40-ml of saline into the other. To
eliminate the need of attaching and detaching syringes when switching from contrast agent
to flushing the saline, incorporate the use of a 3-way stopcock or Y-tubing.
5. Set up the power injector as specified by the manufacturer.
A minimum of 40 ml normal saline should be drawn-up to ensure sufficient saline is
available to keep the vein open (KVO) throughout the exam. There is no need to use a
double dose for hepatic MRI. While the standard on-label dose is 0.1 mmol/kg, this can
safely be rounded up to the nearest bottle size, or a dose of 20 ml can be used routinely.
6. Escort the patient to the MR examination room and ask them to lie down accordingly
with respect to the exam to be performed. Connect the extension tubing secured to
the syringe, to the power injector extension tubing. Review the following items with
the patient:
a. Provide earplugs or headphones to the patient to minimize the loud knocking noise
that will be produced by the gradients but ensure them that they will still be able
to hear you.
b. Provide the patient with a safety squeeze-bulb and demonstrate how it works;
explain to the patient when to use the squeeze-bulb (i.e., if they need assistance
during the exam).
c. Explain to the patient that you will be talking to them between imaging sequences
which will be when the loud knocking noise stops. Additionally, review breath-
holding instructions with the patient.
d. Explain to the patient that it is imperative that they remain motionless during the
loud knocking noise to ensure good results; also explain that they should not
reposition their body between imaging sequences.
e. Nevertheless, the patient may call out at any time if he or she feels it necessary.
f. Provide the patient with an approximate time that the examination will take.
g. Attach the power injector to the i.v., and set it to keep the line open.
7. Place the torso phased array coil on the scanning table. Secure the torso phased array
coil to the patient, centering at the costal margin in most patients. Usually, straps are
provided by the manufacturer that are directly attached to the coil. Place a foam pad
between the patient’s abdomen and the coil to reduce near-field artifacts. Place a
support under the patient’s knees to enhance patient comfort.
8. Place nasal canula for oxygen 2 liters, if available, to aid in suspended respiration.
Hyperventilation before breathholding is helpful. Most helpful is administration of
oxygen during the examination (Marks et al., 1997).
9. Using the laser light, center the patient’s upper abdomen to the coil.
10. Advance the patient table to isocenter.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
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11. Program the power injector for a contrast agent and saline injection rate of 2 ml/sec.
Total volume of saline following contrast agent injection should be programmed for
20 ml. The scan delay in healthy young patients averages 18 sec (contrast agent is
injected, scan is initiated 18 sec after the contrast agent and saline are delivered), but
this is highly variable in the elderly or those with cardiovascular disease.
Although Fisher, Semelka, and Wilber (UNIT A15.1) recommend the routine use on an 18-sec
delay, since this is a good estimate for most healthy individuals, the authors strongly
recommend determination of the optimum delay in each patient. This can either be done
with the automated bolus detection (SMARTPREP, General Electric) feature, or by use of
a 2 ml timing bolus sequence, as per Earls et al. (1997) and described later in this unit.
Both of these methods can be adapted to either hand or power injection.
12. Arm the power injector and keep the vein open. IMPORTANT: Do not inject the
contrast agent.
Sequence 1: Coronal single shot fast spin echo (SSFSE)
Although some technologists precede this with a three-plane orthogonal scout sequence,
the authors find that this can be safely omitted by most experienced technologists. The
coronal single shot fast spin echo (SSFSE) sequence is nearly always of high quality and
high information content (Fig. A15.2.1). These can be acquired using a 320- to 360-mm2
field of view (FOV) and 5- to 8-mm image slices. Using thicker image slices will reduce
the number of slices and save imaging time. Using a large FOV allows additional imaging
of the abdomen and much of the lower chest and upper pelvis in a single breathhold, and
provides added assurance against wrap-around artifact. Alternatively, a smaller FOV and
thinner image slices (5 mm) can be acquired in two or more breathholds to provide greater
detail of biliary and pancreatic ducts. Each breath-hold should cover one slab (with a
certain number of slices) such that the scan time is ∼20 sec. Then move the region of
interest to a new slab. Slabs should be overlapped, not interleaved.
13. Instruct the patient to remain motionless, and to take a deep breath in and blow it out
two times, then hold it. Run the sequence according to the parameters, except with
14 number of slices, listed in Table A15.2.2. Instruct the patient to breathe and hold
their breath, run the sequence to cover the remaining 14 slices.
Figure A15.2.1 T2-weighted coronal single shot FSE sequence used as a localizer, with an
effective TE of 100 msec. Arrow indicates a small cavernous hemangioma.
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Obtaining images during suspended respiration will minimize misregistration and image
blurring. However, it is important to be aware that the absence of visible motion artifact
does not indicate that the patient successfully suspended respiration; the multislice
gradient echo images must be checked for this.
Although some patients may hold their breath longer at full inspiration, more consistent
location and absence of motion are achieved if respiration is suspended at relaxed
expiration.
Observe the respiratory waveform to determine if the patient is complying with breath
holding instructions. Remember that poor compliance will not degrade these images
because of their relative lack of motion sensitivity.
14. Confirm positioning of the torso coil by making certain that all parts of the liver are
included within the sensitive volume of the coil. Reposition the patient and repeat
the sequence, if necessary.
Sequence 2: Heavily T2-weighted (TE = 180 msec) transverse single shot FSE
15. Using the coronal images, position slices to ensure that the entire liver is covered on
transverse images (Fig. A15.2.2). Ask the patient to hold his or her breath and run the
sequence according to the parameters listed in Table A15.2.3.
Sequence 3: Transverse gradient echo in-phase and out-of-phase
If possible, these should be obtained as a dual-echo sequence, with TEs of ∼2.3 msec
(out-of-phase) and 4.6 msec (in-phase; Fig. A15.2.3). If this is not available, separate
in-phase and out-of-phase acquisitions will be necessary. Although the TEs mentioned
above are ideal, software may be configured to yield slightly different TEs, with acceptable
results.
Table A15.2.2 Imaging Parameters for Sequence 1 (Single Shot Fast Spin Echo)
Patient position Supine
Scan type Single shot fast spin echo
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Pulse sequence database (PSD) SSFSE
Central slice or volume center Center to xyphoid
Echo time (TE) 100 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) Infinite
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 360 mm, 360 mm
Resolution (∆x, ∆y) 1.41 mm, 1.92 mm
Number of data points collected (Nx, Ny) 256, ∼100
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 28
Slice gap 0
Number of excitations (NEX) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location A70–P70
Saturation pulses None
Scan time 40 sec
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16. Position slices to cover entire liver, as for sequence 2, adjusting levels if necessary.
Ask the patient to hold his or her breath and run the sequence according to the
parameters listed in Table A15.2.4.
17. Evaluate for image quality.
This is the first motion-sensitive scan, and will therefore be the first to be degraded if breath
holding is not successful. If there is substantial motion artifact, remind the patient about
the importance of breath holding, and repeat the acquisition. Consider reducing coverage
or acquisition matrix, or increasing image thickness, to reduce acquisition time if neces-
sary.
Figure A15.2.2 Heavily T2-weighted transverse single shot FSE image, with effective TE = 180
msec. Arrow indicates the small cavernous hemangioma, with signal intensity intermediate between
that of spleen and cerebrospinal fluid.
Table A15.2.3 Imaging Parameters for Sequence 2 (Single Shot Fast Spin Echo)
Patient position Supine
Scan type Single shot fast spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) SSFSE
Central slice or volume center Center to liver
Echo time (TE) 180 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) Infinite
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.00 mm
Number of data points collected (Nx, Ny) 256, ∼120
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 0
Number of excitations (NEX) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Entire liver
Saturation pulses Superior and inferior
Scan time 24 sec
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Sequence 4: Timing bolus sequence (if automated bolus detection is not used)
If automated bolus detection (e.g., SMARTPREP) is not used, the delay between injection
and scanning should be determined by injecting a 2-ml test bolus, followed by a 20-ml
flush of saline (Earls et al., 1997). The size of the syringe used should be the same as that
used for injecting the bolus of gadolinium chelate, and the speed of injection should be
as identical as possible. The pulse sequence used for the test bolus on GE equipment
should be a single 20-mm sagittal slice short TR gradient echo sequence (60 multi-phases),
A B
Figure A15.2.3 Spoiled gradient echo images: out-of-phase, with TE = 2.3 msec (A) and in-phase, with TE = 4.6 msec (B).
Table A15.2.4 Imaging Parameters for Sequence 3 Dual (Gradient Echo)
Patient position Supine
Scan type 2-D double gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) FGRE-dual
Central slice or volume center Center to liver
Echo time (TE) 2.3 msec and 4.6 msec
Receiver bandwidth (RBW) ±62 kHz
Repeat time (TR) 200 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 3.00 mm
Number of data points collected (Nx, Ny) 256, ∼80
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 0
Number of excitations (NEX) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Entire liver
Saturation pulses Superior, inferior
Scan time 24 sec
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with fields of view 320 mm × 240 mm (3⁄4 fields of view), centered over the upper
abdominal aorta. Each phase should be obtained in ∼1 sec.
If the acquisition of the sequence begins when the flush begins, when the peak signal
intensity in the mid-aorta is shown, the delay time is 5 sec longer than the time it takes
an injection of the contrast agent to travel from the i.v. tubing port to the abdominal aorta.
This should correspond to the delay time between beginning of the major gadolinium
bolus and the beginning of the acquisition. For example, if it takes 25 sec for the
gadolinium to travel from the i.v. tubing port to the mid abdominal aorta, breath-holding
instructions should be given so that the actual pulse sequence begins 30 sec following the
beginning of the gadolinium injection.
18. Inject 2 ml of gadolinium chelate, followed immediately by a 20 ml flush of saline
with an injection of 2 ml/sec.
19. Run sequence 4 according to Table A15.2.5 at the beginning of the flush.
Breath holding is not necessary.
The aorta will have low signal intensity on all of these images, until the 2-ml bolus of
gadolinium arrives, at which point there will be a noticeable increase in aortic signal
intensity (Fig. A15.2.4). The time after the beginning of the acquisition is annotated in the
upper left hand corner of the image as the delay time (DT) and can also be determined by
noting the number of phases, and multiplying by 1 sec and then adding 5 sec.
Sequence 5: Dynamic multi-phasic pre/post contrast 3-D short TR gradient echo
Prescribe the volume to cover the liver. TR and TE should be as short as possible, and the
flip angle should be 12° to 15°. There will be visible contrast in the kidneys and collecting
systems if a timing bolus was used, but there will be no significant effect on the liver.
Obtain images (see Fig. A15.2.5) using the technique described above.
Table A15.2.5 Imaging Parameters for Sequence 4 (Timing Bolus)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Variable bandwidth No
Pulse sequence database (PSD) FGRE
Central slice or volume center Upper abdominal aorta
Echo time (TE) Minimum (∼2.1 msec)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) 7 msec
Flip angle (FA) 70°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.50 mm
Number of data points collected (Nx, Ny) 256, 96
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 20 mm
Number of slices 1
Slice gap N/A
Number of excitations (NEX) 1
Swap read and phase encoding No
Saturation pulses None
Multi-phase 60
Scan time 50 sec
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A B
Figure A15.2.4 Selected images from sagittal timing bolus sequence, without (A) and during (B) aortic enhance-
ment (arrows) from the 2-ml bolus of gadolinium chelate.
A B
C
Figure A15.2.5 3-D fat-suppressed short TR gradient echo images with TR/TE = 4 msec/1.3 msec, and flip angle = 12°,
before (A), immediately after (B), and 45 sec after (C) gadolinium chelate injection. Through Fourier interpolation, images
are reconstructed every 2.5 mm. Arrows indicate the cavernous hemangioma, which does not show enhancement in A.
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20. Instruct the patient to hold his/her breath. Run the 3-D gradient echo sequence
according to Table A15.2.6.
21. Explain to the patient that the contrast agent will now be injected and that they may
feel a cool sensation in their arm. Initiate the injection. IMPORTANT: Do not begin
scanning until the scan delay (determined by the timing bolus procedure) has expired.
However, breathing instructions should be initiated when ∼5 sec of delay are remain-
ing.
If a power injector is not accessible and one is “hand”-injecting, reattach the saline-filled
syringe and flush with 20 ml of saline. The process of switching syringes must be completed
as quickly as possible and therefore, it is recommended to use of a three-way stopcock.
22. Obtain a first set of post-contrast images according to Table A15.2.6 as soon as
possible. Repeat the same breath-holding procedure as in step 20. Allow the patient
∼5 sec to breathe and obtain a second identical set of post-contrast acquisitions.
Sequence 6: Moderately T2-weighted FSE with fat suppression
23. Prescribe the volume to cover the liver. Usually, this will require two separate
overlapping breath-holdings.
IMPORTANT: Do not obtain these as interleaved images. The “pause before scan” must
be set as “none.”
Other than causing lower signal intensity of kidneys and renal collecting structures, the
previously administered gadolinium will have little effect on the image, although there may
be slightly improved conspicuity of solid liver lesions (Jeong et al., 2001). Other advantages
of performing this sequence after contrast agent administration include obtaining the
Table A15.2.6 Imaging Parameters for Sequence 5 (Dynamic 3-D Gradient Echo)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) LUFGRE3D
Central slice or volume center Center to liver
Echo time (TE) Minimum (∼1.5 msec)
Receiver bandwidth (RBW) ±62 kHz
Repeat time (TR) 4 msec
Flip angle (FA) 12°-15°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 3.00 mm
Number of data points collected (Nx, Ny) 256, ~80
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 64
Slice gap −2.5 mm (50% overlap)
Number of excitations (NEX) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Cover the entire liver
ZIP2 Yes
Saturation pulses None
Fat suppression Yes, spectral inversion at lipids
(SPECIAL)
Scan time 24 sec
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important contrast-enhanced images earlier and allowing a longer interval before obtain-
ing the delayed post-contrast images.
24. Instruct the patient to hold his/her breath and run sequence 6 according to Table
A15.2.7 (Fig. A15.2.6) with 13 slices. Allow the patient to breathe for 10 seconds,
then instruct the patient to hold his/her breath and run the sequence for the additional
13 slices.
Sequence 7: Transverse gradient echo with fat suppression
TR should be ∼20 msec in this sequence. These images show delayed extracellular space
contrast, and all vessels are white because of the combined effects of gadolinium and time
Table A15.2.7 Imaging Parameters for Sequence 6 (Fast Spin Echo)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) FRFSE-OPT
Central slice or volume center Center to liver
Echo time (TE) 82 msec (effective)
Receiver bandwidth (RBW) ±62 kHz
Echo train length (ETL) 19
Repeat time (TR) 2850 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 1.67 mm
Number of data points collected (Nx, Ny) 256, ∼144
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 7 mm
Number of slices 26
Slice gap 0.5 mm
Number of excitations (NEX) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Cover the liver
Saturation pulses Superior, inferior
Fat suppression Yes
Scan time 46 sec
Figure A15.2.6 Moderately T2-weighted FSE breath-hold image, with TR = 2850 msec, effective
TE = 82 msec. Arrow indicates hemangioma.
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of flight (Fig. A15.2.7). Motion artifact is minimal because the short TR allows completion
of each image in <2 sec.
25. Instruct the patient to hold his/her breath and run sequence 7 according to Table
A15.2.8.
The breath-hold instruction and the way to run this sequence is similar to step 20.
Figure A15.2.7 Two-min post-gadolinium fat-suppressed short TR gradient echo transverse
image (extracellular-phase) demonstrates delayed contrast enhancement, including the cavernous
hemangioma (arrow).
Table A15.2.8 Imaging Parameters for Sequence 7 (Fat Suppressed Gradient
Echo)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth No
Pulse sequence database (PSD) FSPGR
Central slice or volume center Center to liver
Echo time (TE) Minimum (∼2.2 msec)
Receiver bandwidth (RBW) ±16 kHz
Repeat time (TR) 20 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.00 mm
Number of data points collected (Nx, Ny) 256, 120
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices ∼30
Slice gap 0
Number of excitations (NEX) 1
Swap read and phase encoding No
Slice location Cover the liver
Fat suppression Yes
Scan time ∼60 sec
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COMMENTARY
Background Information
A comprehensive protocol for liver imaging
that includes in-phase and out-of-phase T1-
weighted images, moderately and heavily T2-
weighted, and early and late post-gadolinium
images is described. Each sequence is acquired
in one or more breath holds. Total image acqui-
sition time is, therefore, only a few minutes.
Most time is spent with patient set-up and with
inter-sequence delays. By working efficiently,
the entire study can be performed in ≤30 min,
and will decrease further with user interface
enhancements.
At the authors’ institution, body MRI studies
are obtained from several MRI instruments,
including 8 GE Signa scanners at six separate
locations. Although referring clinicians are en-
couraged to include ample clinical information,
their compliance with this is highly variable. A
set protocol, as described here, ensures that the
full spectrum of liver diseases will be detected
and characterized without requiring physician
intervention. When necessary, attending radi-
ologists can be contacted by phone to give
pertinent directions regarding troubleshooting
or addressing unusual requests.
Critical Parameters and
Troubleshooting
The two major potential problems with this
protocol are that patients may not be able to
suspend respiration or timing of gadolinium
administration may be incorrect. The first prob-
lem can be addressed by replacing sequence 5
with short TR (≤10 msec) single-slice T1-
weighted 2-D gradient echo sequences with a
flip angle of ∼30°. The second problem is pre-
vented in most cases by using a test dose of
gadolinium to determine timing (Earls et al.,
1997), or by using an automated detection
method such as SMARTPREP.
Another problem occurs in patients with
implanted metal, such as from surgical clips.
Artifacts from metal on gradient echo images
can be minimized by using the shortest possible
TE and avoiding fat suppression. TE on the 3-D
short TR gradient echo sequence is minimized
by increasing the number of excitations (NEX)
from 0.5 to 1.0, and increasing the sampling
bandwidth from ±31 to ±62 kHz. The acquisi-
tion time will be slightly longer, so adjustments
in the number of image slices and/or acquisition
matrix may be necessary.
Other Contrast Agents
With good single breath-hold whole-liver
dynamic technique, gadolinium chelates are
generally considered preferable to other con-
trast agents for routine liver imaging. Manga-
fodipir trisodium (Teslascan) or ferumoxides
(Feridex) may be considered in some cases,
especially those who have already had an
equivocal gadolinium-enhanced exam, or to
exclude additional tumors prior to curative sur-
gery or ablation.
Anticipated Results
Most reports comparing MRI and computed
tomography (CT) indicate that MRI has higher
sensitivity for detecting liver lesions. More im-
portantly, it is more specific for distinguishing
benign from malignant lesions. This is partly
because the smaller volume of contrast agent
and paramagnetic effect of gadolinium contrast
agents results in a stronger imaging effect than
that of iodinated contrast agents in CT. Addi-
tionally, the use of moderately and heavily
T2-weighted images provides benefits for de-
tecting and characterizing, respectively, focal
liver lesions beyond what can be obtained using
contrast agents. Heavily T2-weighted breath-
hold images, in particular, allow distinction
between benign and malignant lesions in most
cases even before the contrast agent is injected
(Ito et al., 1997).
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mended safety procedures, a list of metallic implants
that have been tested for MR compatibility, and a
list of other sources on MR safety.
Internet Resources
http://www.mri.tju.edu
A noncommercial site that lists all body MRI proto-
cols, continually updated, updated GE Signa scan-
ners by the Thomas Jefferson University Depart-
ment of Radiology. Additionally, there are descrip-
tions and explanations of the various pulse
sequences, tips for problems solving, and examples
of clinical applications.
http://www.mrisafety.com
Managed by Frank Shellock, contains updated items
regarding MRI safety and compatibility.
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